1、シオノケミカル株式會(huì)社サラゾスルファピリジン腸溶錠250mg「SN」の生物學(xué)的同等性に関する資料， 2、Temperature- and rigidity-mediated rapid transport of lipid nanovesicles in hydrogels 3、J Pharm Sci. 2016 Sep;105(9):2855-2863. doi: 10.1016/j.xphs.2016.03.006. Epub 2016 Apr 19. 4、https://www.sciencedirect.com/science/article/abs/pii/S0925443918300899 5、Martindale: The Complete Drug Reference, 2017, The Pharmaceutical Press. 6、http://jcmr.um.ac.ir/index.php/biology/article/view/36148 7、Benefits and harms of sugammadex versus neostigmine in reversing induced paralysis 8、Current Therapeutic Drugs Against Cerebral Vasospasm after Subarachnoid Hemorrhage: A Comprehensive Review of Basic and Clinical Studies. Curr Drug Deliv. 2017 Sep 6;14(6):843-852. doi: 10.2174/1567201813666160808100937 9、Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests 10、Blood Purif. 2018 Nov 28:1-8. doi: 10.1159/000495024. [Epub ahead of print] Risk Factors of Central Venous Catheter-Related Bloodstream Infection for Continuous Renal Replacement Therapy in Kidney Intensive Care Unit Patients. Cheng S1, Xu S1, Guo J1, He Q1, Li A1, Huang L1, Liu Z1, Li S2. 11、中國(guó)制藥信息2013年第29卷第2期：34-36 12、Chen et al. J Clin Endocrinol Metab, May 2015, 100(5). 1912-1919 13、 NUTRIENTS 2017 , 9 ( 2 ) , 138 14、Fan et al Journal of paediatrics and child health. Volume 52, Issue s2 2016 15、Association Between Vitamin D Supplementation During Pregnancy and Offspring Growth, Morbidity, and MortalityA Systematic Review and Meta-analysis 16、Effect of Higher vs Standard Dosage of Vitamin D3 Supplementation on Bone Strength and Infection in Healthy InfantsA Randomized Clinical Trial 17、Prenatal Vitamin D Supplementation to Improve Health in Offspring 18、Digoxin bioequivalence study: determination in human plasma by microparticle enzyme immunoassay. 19、文獻(xiàn)題目Dimeticone、刊名：Reactions Weekly, 2019, Vol.1752 (1), pp.137-137 20、Curr Neuropharmacol. 2018 Aug 27. Rothenberger A1, Roessner V2. Psychopharmacotherapy of   [更多]

賞金領(lǐng)?。?8*3+35*5=229   [更多]

需求幾十篇文獻(xiàn) 1.Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer 2、J Clin Gastroenterol. 2016 Jan;50(1):e1-7. Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. Tan VP1, Wong BC, Wong WM, Leung WK, Tong D, Yuen MF, Fass R. 3、Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Gut. 2018 Mar;67(3):430-440. 4、The prevalence and risk factors of reflux esophagitis among adult Chinese population in Taiwan. Chen TS, Chang FY. J Clin Gastroenterol. 2007 Oct;41(9):819-22. 5、 Circulation. 1998 Nov 24;98(21):2282-9. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Senni M1, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. 6、 Anesth Analg. 2018 Nov 9. doi: 10.1213/ANE.0000000000003887. [Epub ahead of print] Side Effect Rates of Opioids in Equianalgesic Doses Via Intravenous Patient-Controlled Analgesia: A Systematic Review and Network Meta-analysis. 7. Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD 8.Macromolecules, 1983, 16 (8), pp 1367-1374DOI: 10.1021/ma00242a019 Publication Date: August 1983 ACS Legacy Archive 9、Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats Kai Zhang Zuowang Ma Weiding Wang Ruimeng Liu Yue Zhang Meng Yuan Guangping Li 10、Vascular. 2018 Dec;26(6):626-633. Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia. 嚴(yán)重肢體缺血患者潰瘍愈合和無(wú)截肢生存的預(yù)后因素 Furuyama T, Onohara T, Yamashita S, Yoshiga R, Yoshiya K, Inoue K, Morisaki K, Kyuragi R, Matsumoto T, Maehara Y. 11、Curr Drug Discov Technol. 2018 Oct 8. Aripiprazole: An FDA Approved Bioactive Compound to treat schizophrenia-A Mini Review.   [更多]

求DOF 2019年1-3期文獻(xiàn)   [更多]

1、總共7份文件，一份400條，一份240元。2、要求藥學(xué)相關(guān)的專業(yè)人員，英語(yǔ)翻譯能力強(qiáng)。3、要求翻譯準(zhǔn)確度要高。4、過(guò)多和軟件翻譯內(nèi)容重合則為不合格。   [更多]

①文獻(xiàn)和網(wǎng)站來(lái)源必須權(quán)威、專業(yè)，盡量找外文或官網(wǎng)的文獻(xiàn)或報(bào)道，不能是百度百科等； ②簡(jiǎn)要概述的語(yǔ)句具有邏輯性和連貫性。 ③由于藥物本身存在信息不全或難找到信息源，以及藥物概述質(zhì)量不定（如翻譯質(zhì)量不定等）的情況，賞金酌情給出，請(qǐng)諒解。 ④單價(jià)8元/條，質(zhì)量偏低需折價(jià)計(jì)算。 30條合格，30*8=240   [更多]

①文獻(xiàn)和網(wǎng)站來(lái)源必須權(quán)威、專業(yè)，盡量找外文或官網(wǎng)的文獻(xiàn)或報(bào)道，不能是百度百科等； ②簡(jiǎn)要概述的語(yǔ)句具有邏輯性和連貫性。 ③由于藥物本身存在信息不全或難找到信息源，以及藥物概述質(zhì)量不定（如翻譯質(zhì)量不定等）的情況，賞金酌情給出，請(qǐng)諒解。 ④單價(jià)8元/條，質(zhì)量偏低需折價(jià)計(jì)算。 30條合格，30*8=240 *此任務(wù)金額為不含稅金額，按照國(guó)家稅務(wù)相關(guān)法律法規(guī)，提現(xiàn)時(shí)個(gè)稅由藥智匯代扣代繳   [更多]

240份合格說(shuō)明書賞金領(lǐng)取處，請(qǐng)?zhí)峁┖细竦恼f(shuō)明書稿件的威客在下方投稿   [更多]

240份合格說(shuō)明書賞金領(lǐng)取處，請(qǐng)?zhí)峁┖细竦恼f(shuō)明書稿件的威客在下方投稿   [更多]

DrugsoftheFuture（DOF）2020年5-7期 文獻(xiàn)必須完整、準(zhǔn)確   [更多]